QMS Medical Allied Services Limited (NSE:QMSMEDI)
India · Delayed Price · Currency is INR 164.50
+6.52 (4.13%)
Sep 15, 2026, 10:55 AM IST
NSE:QMSMEDI Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Revenue | 1,832 | 1,729 | 1,560 | 1,221 | 1,040 | 1,463 |
Other Revenue | -0 | - | - | - | - | 0.01 |
| 1,832 | 1,729 | 1,560 | 1,221 | 1,040 | 1,463 | |
Revenue Growth | 6.45% | 10.81% | 27.75% | 17.38% | -28.89% | 19.90% |
Cost of Revenue | 928.71 | 926.27 | 816 | 799.24 | 778.84 | 1,103 |
Gross Profit | 903.78 | 802.5 | 744.15 | 422.04 | 261.59 | 360.14 |
Selling, General & Admin | 231.74 | 177.83 | 127.56 | 67.88 | 55.18 | 46.66 |
Other Operating Expenses | 395.53 | 365.64 | 362.51 | 170.3 | 92.68 | 147.13 |
Operating Expenses | 672.01 | 582.87 | 528.32 | 272.58 | 158.59 | 205.41 |
Operating Income | 231.76 | 219.63 | 215.82 | 149.45 | 103 | 154.73 |
Interest Expense | -68.27 | -58.99 | -45.12 | -28.82 | -19.98 | -21.23 |
Interest & Investment Income | - | 10.53 | 13.86 | 4.56 | 6.23 | - |
Currency Exchange Gain (Loss) | - | -0.25 | 0.52 | -0.4 | 0.7 | 0.74 |
Other Non Operating Income (Expenses) | 11.52 | -6.53 | 1.38 | -2.43 | -2.9 | -3.19 |
EBT Excluding Unusual Items | 175.01 | 164.4 | 186.46 | 122.36 | 87.05 | 131.05 |
Gain (Loss) on Sale of Assets | - | - | 0.16 | - | - | 13.51 |
Pretax Income | 175.01 | 164.4 | 186.62 | 122.36 | 87.05 | 144.56 |
Income Tax Expense | 47.86 | 45.23 | 49.64 | 32.33 | 23.27 | 37.7 |
Earnings From Continuing Operations | 127.15 | 119.17 | 136.98 | 90.02 | 63.78 | 106.86 |
Minority Interest in Earnings | -18.59 | -17.85 | -16.06 | - | - | - |
Net Income | 108.56 | 101.32 | 120.92 | 90.02 | 63.78 | 106.86 |
Net Income to Common | 108.56 | 101.32 | 120.92 | 90.02 | 63.78 | 106.86 |
Net Income Growth | -14.02% | -16.21% | 34.32% | 41.14% | -40.31% | -2.12% |
Shares Outstanding (Basic) | 20 | 19 | 18 | 18 | 16 | 15 |
Shares Outstanding (Diluted) | 20 | 19 | 18 | 18 | 16 | 15 |
Shares Change | 11.45% | 3.34% | 1.80% | 9.05% | 8.76% | 33.33% |
EPS (Basic) | 5.46 | 5.40 | 6.65 | 5.04 | 3.90 | 7.10 |
EPS (Diluted) | 5.46 | 5.40 | 6.65 | 5.04 | 3.90 | 7.10 |
EPS Growth | -22.80% | -18.87% | 31.94% | 29.34% | -45.12% | -26.59% |
Additional Metrics
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Free Cash Flow | - | 136.5 | 157.3 | -11.94 | -288.46 | -38.05 |
Free Cash Flow Per Share | - | 7.27 | 8.66 | -0.67 | -17.62 | -2.53 |
Dividend Per Share | - | 0.500 | 0.500 | 0.500 | 0.500 | - |
Dividend Growth | - | 0% | 0% | 0% | - | - |
Gross Margin | 49.32% | 46.42% | 47.70% | 34.56% | 25.14% | 24.61% |
Operating Margin | 12.65% | 12.71% | 13.83% | 12.24% | 9.90% | 10.57% |
Profit Margin | 5.92% | 5.86% | 7.75% | 7.37% | 6.13% | 7.30% |
Free Cash Flow Margin | - | 7.90% | 10.08% | -0.98% | -27.73% | -2.60% |
EBITDA | 272.89 | 252.03 | 248.28 | 181.55 | 113.62 | 165.42 |
EBITDA Margin | 14.89% | 14.58% | 15.91% | 14.87% | 10.92% | 11.30% |
D&A For EBITDA | 41.13 | 32.4 | 32.46 | 32.1 | 10.62 | 10.69 |
EBIT | 231.76 | 219.63 | 215.82 | 149.45 | 103 | 154.73 |
EBIT Margin | 12.65% | 12.71% | 13.83% | 12.24% | 9.90% | 10.57% |
Effective Tax Rate | 27.35% | 27.51% | 26.60% | 26.43% | 26.73% | 26.08% |
Revenue as Reported | 1,844 | 1,739 | 1,577 | 1,226 | 1,048 | 1,477 |
Advertising Expenses | - | 11.69 | 21.74 | 9.98 | 10.23 | 0.88 |